• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TAH-T; BIVENTRICULAR REPLACEMENT DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TAH-T; BIVENTRICULAR REPLACEMENT DEVICE Back to Search Results
Catalog Number 500101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Hemorrhage/Bleeding (1888); Neurological Deficit/Dysfunction (1982); Urinary Tract Infection (2120); Viral Infection (2248); Respiratory Failure (2484); Thromboembolism (2654)
Event Type  Injury  
Manufacturer Narrative
The syncardia 70cc temporary total artificial heart (tah-t) is an implantable pulsatile biventricular replacement device that replaces a patient's native ventricles and valves and pumps blood to both the pulmonary and systemic circulation systems.The syncardia 70cc tah-t is indicated for use as a bridge to transplantation in cardiac transplant-eligible candidates at risk of imminent death from biventricular failure.The syncardia tah-t system is intended for use inside and outside the hospital.Investigation summary: intermacs patient registry data collected between april 1, 2014 and september 30, 2017 regarding adverse events was retrospectively reviewed.Patients were de-identified therefore a one-to-one correlation could not be made between the patient and the lot number of the implanted tah-t.These events were assessed and are being reported in response to an update to the mdr complaint sources.With a review of the available information, there is no evidence of a device malfunction or performance issues that would impact the reported events.Possible clinical factors that may have contributed to these events include the patients pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulants, antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to these events.This device is used for treatment, not diagnosis.If new or additional information is received in the future, syncardia will file a follow-up mdr.(b)(4).
 
Event Description
While supported by the tah-t, the patient has experienced the following adverse events as defined by intermacs: 252 days post implant - device malfunction and/or pump thrombosis; 289 days post implant - bleeding; 268 days post implant - device malfunction and/or pump thrombosis; 10 days post implant - venous thromboembolism; 59 days post implant - infection/location: urinary tract/type: bacterial; 199 days post implant - infection/location: other/type: viral; 444 days post implant - bleeding; 433 days post implant - device malfunction and/or pump thrombosis; 444 days post implant - neurological dysfunction - seizure; 444 days post implant - respiratory failure.As of (b)(6) 2017 it was reported that the patient was still supported by the tah-t.
 
Event Description
Since the last reporting period, the patient experienced the following adverse events as defined by intermacs: 5 days post implant - respiratory failure, 11 days post implant - infection i location: pulmonary i type: bacterial, 90 days post implant - device malfunction and/or pump thrombosis, 176 days post implant - neurological dysfunction - tia, 536 days post implant - infection i location: positive blood cultures i type: bacterial, as of (b)(6) 2018 it was reported that the patient was still supported by the tah-t.
 
Manufacturer Narrative
Intermacs patient registry data collected from (b)(6) 2017 through (b)(6) 2018 regarding adverse events was reviewed.Patients were de-identified therefore a one-to-one correlation could not be made between the patient and the lot number of the implanted tah-t.Ce 4693 pt 105514 follow-up report 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCARDIA 70CC TAH-T
Type of Device
BIVENTRICULAR REPLACEMENT DEVICE
Manufacturer (Section D)
SYNCARDIA SYSTEMS, LLC
1992 e. silverlake road
tucson AZ 85713
MDR Report Key7731446
MDR Text Key115390154
Report Number3003761017-2018-00395
Device Sequence Number1
Product Code LOZ
Combination Product (y/n)N
PMA/PMN Number
P030011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Remedial Action Inspection
Type of Report Initial,Followup
Report Date 05/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number500101
Date Manufacturer Received04/08/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight150
-
-